Results 201 to 210 of about 115,857 (253)

Clinical Impact of Next-Generation Sequencing-Detected Mutations on Thrombotic Events in Myeloproliferative Neoplasms. [PDF]

Int J Lab Hematol
Yigitbasi A, Umit EG, Puyan FO, Kirkizlar HO, Kirkizlar TA, Can N, Aygun G, Demir AM.   +7 more
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasms. [PDF]

Front Oncol
Barbui T.
europepmc   +1 more source

Elevated P-RBC complexes are associated with thrombotic risk and diagnostic potential in myeloproliferative neoplasms: a retrospective cohort study. [PDF]

Am J Transl Res
Niu X, Jia C, Ma Y, Huang X, Li C.
europepmc   +1 more source

Glucose transport dependency defines a therapeutic vulnerability in JAK2V617F-driven myeloproliferative neoplasms. [PDF]

Cell Commun Signal
Weiand P, Chatain N, de Toledo MAS, Moellmann J, Pirker T, Gupta S, Jacobi H, Lazarevic J, Vieri M, Rodriguez MJ, Koschmieder S, Nogueira Gezer D, Baumeister J.   +12 more
europepmc   +1 more source

Practical Guide for Managing Philadelphia-Negative Myeloproliferative Neoplasms in Patients with Organ Dysfunction.

Oncology
Abdulsalam S, Al-Shibly R, Kaddoura R, Ismail OM, Yassin MA.   +4 more
europepmc   +1 more source

Implementation of a nurse-led visit and follow-up for patients with myeloproliferative neoplasms: a quality improvement project. [PDF]

BMJ Open Qual
Berardinelli D, Fava C, Sinisi F, Ventimiglia I, Maglione I, Ricotti A, Mentone C, Bonuomo V, Grano S, Campagna S, Di Giulio P, Dimonte V.   +11 more
europepmc   +1 more source

Characterization of JAK2V617F and the JAK2 46/1 germline haplotype in myeloproliferative neoplasms in a Saudi Arabian cohort: a case-based analysis. [PDF]

Front Oncol
Mutrib N, Alqarni S, Peer-Zada AA, Samman M, Fatima S, Arjumand S, Aldahshan H, Alharbi KK, AlRashed MM.   +8 more
europepmc   +1 more source

Risk stratification of patients with TP53-mutated myeloproliferative neoplasms. [PDF]

Leukemia
Rolles B, Filho CMO, Fergusson N, Bewersdorf JP, Keating J, Perkins C, Schwede M, England J, Luskin MR, DeAngelo DJ, Shimony S, Faiz M, Hillerbrand AC, Kim C, Weeks LD, Waldman L, Wazir M, How J, Marneth AE, Liu Y, Aryee MJ, Rampal R, Tsai HK, Gotlib J, Gupta V, Stahl M, Mullally A.   +26 more
europepmc   +1 more source

Telehealth-Delivered Dietary Counseling in Myeloproliferative Neoplasms: A Randomized Feasibility Study. [PDF]

Nutrients
Fleischman A, Li J, Tabban A, Cai S, Odegaard A.   +4 more
europepmc   +1 more source

MPL mutations are over-represented in patients with dual driver-mutated myeloproliferative neoplasms: an Irish cohort study. [PDF]

Hematol Transfus Cell Ther
Kearney L, Andrews C, Brodie R, Elhassadi E, Enright H, Fadalla K, Fay M, Flynn C, Fortune A, Hodgson A, Kumar S, Perera K, Sargent J, Smyth L, Langabeer SE.   +14 more
europepmc   +1 more source